Interviews

Joe Moose, owner of Moose Professional Pharmacy, discusses how pharmacy technicians can better prepare themselves for the shifting pharmacy landscape.

Joe Moose, owner of Moose Professional Pharmacy, predicts how the pharmacy technician profession will continue to evolve.

Joe Moose, owner of Moose Professional Pharmacy, discusses the new responsibilities that pharmacy technicians are assuming.

Joe Moose, owner of Moose Professional Pharmacy, discusses how the roles of pharmacy technicians have changed.

National Association of Specialty Pharmacy (NASP) Executive Director James E. Smeeding, RPh, MBA, discusses methods specialty pharmacies can use to help patients access high cost medications.

Dan Benamoz, RPh, President and CEO of Pharmacy Development Services, discusses how the movement toward value-based care has changed independent pharmacists' business goals.

Jerry McKee, PharmD, assistant director of Community Care of North Carolina, discusses the goals of the Pharmacy Home Project.

Jerry McKee, PharmD, assistant director of Community Care of North Carolina, discusses his organization's mission.

Dan Benamoz, RPh, President and CEO of Pharmacy Development Services, discusses the technology trends that independent pharmacists should endeavor to familiarize themselves with.

Michael Zeglinski, vice president of Specialty Pharmacy Operations at BriovaRx, discusses how specialty pharmacies can leverage technology to improve the consumer experience.

David D'Altorio, PharmD, senior vice president of health services at MedImpact Healthcare Systems, discusses the benefits of MedImpact's iRx program.

Jon Hamrick, executive vice president, Biotech and Specialty Services at Therigy LLC, discusses the implications of rising drug costs on specialty pharmacy.

National Association of Specialty Pharmacy (NASP) Executive Director James E. Smeeding, RPh, MBA, discusses the relationship between specialty pharmacies and accountable care organizations.

National Association of Specialty Pharmacy (NASP) Executive Director James E. Smeeding, RPh, MBA, discusses the potential of biosimilars to reduce the cost burden of specialty pharmaceuticals.

Michael Zeglinski, vice president of Specialty Pharmacy Operations at BriovaRx, discusses how expensive hepatitis C drugs have impacted the specialty landscape.

David D'Altorio, PharmD, senior vice president of health services at MedImpact Healthcare Systems, discusses how specialty pharmacies can enhance their operations with data analytics.

David Lassen, chief clinical officer at Prime Therapeutics, discusses important developments in specialty pharmacy.

Heather Bonome, PharmD, director of Pharmacy Segment at URAC, discusses what comprises an effective pharmacy accreditation program.

Marc O'Connor, chief operating officer of Curant Health, discusses potential changes patients of specialty pharmacies may experience in the near future.

David Lassen, chief clinical officer at Prime Therapeutics, discusses how high cost hepatitis C drugs have impacted the entire specialty landscape.

David D'Altorio, PharmD, senior vice president of health services at MedImpact Healthcare Systems, discusses methods to improve communication among drug manufacturers and health care providers.

Alexander Kantorovich, PharmD, BCPS, clinical assistant professor of pharmacy practice at Chicago State University College of Pharmacy, discusses the role of the pharmacist in acute coronary syndrome management with platelet aggregation inhibitors.

Jon Hamrick, executive vice president, Biotech and Specialty Services at Therigy LLC discusses the use of technology to optimize clinical services in specialty pharmacy.

Alexander Kantorovich, PharmD, BCPS, clinical assistant professor of pharmacy practice at Chicago State University College of Pharmacy, discusses how platelet aggregation inhibitors fit into the acute coronary syndrome management picture.

Alexander Kantorovich, PharmD, BCPS, clinical assistant professor of pharmacy practice at Chicago State University College of Pharmacy, discusses how closer integration of pharmacists into care teams improves outcomes for patients taking new oral anticoagulants.

Joseph Morse, president and chief operating officer of Therigy, LLC, discusses how specialty pharmacies can meet the reporting requirements required by manufacturers and payers.

Michael Zeglinski, vice president of Specialty Pharmacy Operations at BriovaRx, discusses how specialty pharmacies can help patients manage increasing copay costs.

Aaron Steffenhagen, PharmD, BCPS, clinical pharmacy manager at University of Wisconsin Hospital and Clinics, discusses what documentation and communication a pharmacist could provide in emergency situations.